Point72 Asia (Singapore) Pte. Ltd. Jazz Pharmaceuticals PLC Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,117 shares of JAZZ stock, worth $287,933. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,117
Previous 14,593
85.49%
Holding current value
$287,933
Previous $1.63 Billion
83.97%
% of portfolio
0.07%
Previous 0.31%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$836 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$821 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$344 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$301 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$277 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.53B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...